Specialty Pharmacy

Lucid Diligence Brief - BioPharma

Warburg Pincus PANTHERx Rare Acquisition | Lucid Diligence Brief

Warburg Pincus to acquire control of PANTHERx Rare, backing expansion of the…

by Eugenia Tsempera

Lucid Diligence Brief - Tech

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership Professional…

by Timos Papagatsias

Rare Disease news

Rare Diseases Weekly News - September 11th 2025

🧬 This Week in Rare Diseases: Servier Fragile X deal, FDA RDEP, Bylvay Canada…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.